Trials / Conditions / Pathologic Stage II Esophageal Adenocarcinoma AJCC v8
Pathologic Stage II Esophageal Adenocarcinoma AJCC v8
6 registered clinical trials studyying Pathologic Stage II Esophageal Adenocarcinoma AJCC v8 — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Active Not Recruiting | Testing the Addition of the Anti-cancer Viral Therapy Telomelysin™ to Chemoradiation for Patients With Advance NCT04391049 | NRG Oncology | Phase 1 |
| Recruiting | NBTXR3, Chemotherapy, and Radiation Therapy for the Treatment of Esophageal Cancer NCT04615013 | M.D. Anderson Cancer Center | Phase 1 |
| Completed | Real-Time Monitoring of Chemotherapy Side-Effects in Patients With Gastrointestinal Cancers, RT-CAMSS Study NCT04449679 | Thomas Jefferson University | N/A |
| Completed | Remote Telemonitoring of Patient-Generated Physiologic Health Data and Patient-Reported Outcomes NCT04501913 | City of Hope Medical Center | — |
| Completed | Characterizing Chemo-Radiotherapy Treatment-Related Cardiac Changes NCT04183218 | Mayo Clinic | — |
| Active Not Recruiting | Phase I/II Study of Perioperative Chemotherapy Plus Immunotherapy Followed by Surgery in Localized Esophageal NCT03784326 | M.D. Anderson Cancer Center | Phase 2 |